A recent study revealed that an XBP1 gene signature was expressed at significantly higher levels in ERα+ or non-triple-negative breast cancer samples than in ERα- or triple-negative breast cancer samples, respectively [42]. Here, XBP1 is linked to triple-negative breast carcinoma.